Weight Regain Risk: The Clinical Evidence Research published in major obesity journals reveals that approximately 70% of patients regain weight after stopping GLP-1 therapy without concurrent lifestyle modifications
An eco-friendly and green formulation in lipid nanotechnology for delivery of a hydrophilic agent to the skin in the treatment and management of hyperpigmentation complaints: arbutin niosome (Arbusome)
Yes, sermorelin is frequently used alongside testosterone replacement therapy
GLP-1 Agents: From Diabetes Treatment to Preventive Signal GLP-1 receptor agonistssuch as Semaglutide, Liraglutide, and Dulaglutidewere originally developed for glycemic control in type 2 diabetes
If that describes you, the front thigh is a reliable primary site, and your provider can help you assess which works best for your body composition
These digest slowly, produce a gradual blood sugar response and provide fibre that extends satiety